{"DataElement":{"publicId":"6685471","version":"1","preferredName":"International Metastatic Renal Cell Carcinoma Database Consortium Criteria Assessment Category","preferredDefinition":"The risk category related to an assessment of international metastatic renal cell carcinoma database consortium (IMDC) criteria.","longName":"6685470v1.0:6683974v1.0","context":"Alliance","contextVersion":"1","DataElementConcept":{"publicId":"6685470","version":"1","preferredName":"International Metastatic Renal Cell Carcinoma Database Consortium Criteria Assessment","preferredDefinition":"A validated risk prediction tool for patients with metastatic renal cell carcinoma (mRCC) receiving first-line targeted therapy. The model considers: Karnofsky performance status less than 80%, time from diagnosis to first-line targeted therapy less than 1 year, hemoglobin concentration less than lower limit of normal, neutrophil count greater than upper limit of normal, platelet count greater than upper limit of normal, and serum calcium concentration greater than upper limit of normal._The final result of a determination of the value, significance, or extent of.","longName":"6685468v1.0:2465182v1.0","context":"Alliance","contextVersion":"1","ObjectClass":{"publicId":"6685468","version":"1","preferredName":"International Metastatic Renal Cell Carcinoma Database Consortium Criteria","preferredDefinition":"A validated risk prediction tool for patients with metastatic renal cell carcinoma (mRCC) receiving first-line targeted therapy. The model considers: Karnofsky performance status less than 80%, time from diagnosis to first-line targeted therapy less than 1 year, hemoglobin concentration less than lower limit of normal, neutrophil count greater than upper limit of normal, platelet count greater than upper limit of normal, and serum calcium concentration greater than upper limit of normal.","longName":"C155843","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Metastatic Renal Cell Carcinoma Database Consortium Criteria","conceptCode":"C155843","definition":"A validated risk prediction tool for patients with metastatic renal cell carcinoma (mRCC) receiving first-line targeted therapy. The model considers: Karnofsky performance status less than 80%, time from diagnosis to first-line targeted therapy less than 1 year, hemoglobin concentration less than lower limit of normal, neutrophil count greater than upper limit of normal, platelet count greater than upper limit of normal, and serum calcium concentration greater than upper limit of normal.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"858EBF1B-24A8-6B1F-E053-F662850A1A89","latestVersionIndicator":"Yes","beginDate":"2019-04-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-04-02","modifiedBy":"ONEDATA","dateModified":"2019-04-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2465182","version":"1","preferredName":"Assessed","preferredDefinition":"Having determined the value, significance, or extent of.","longName":"C25217","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F836E72-26FF-3EB2-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-03-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2006-03-22","modifiedBy":"ONEDATA","dateModified":"2006-03-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"858EBF1B-24B6-6B1F-E053-F662850A1A89","latestVersionIndicator":"Yes","beginDate":"2019-04-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-04-02","modifiedBy":"MORENOC","dateModified":"2019-11-07","changeDescription":"11/7/2019: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6683974","version":"1","preferredName":"IMDC Risk Criteria Category","preferredDefinition":"The International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) risk criteria category.","longName":"6683974v1.0","context":"Alliance","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Intermediate risk","valueDescription":"International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Criteria - Intermediate-Risk Group","ValueMeaning":{"publicId":"6684007","version":"1","preferredName":"International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Criteria - Intermediate-Risk Group","longName":"6684007","preferredDefinition":"A patient with 1-2 IMDC risk factors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Criteria - Intermediate-Risk Group","conceptCode":"C155845","definition":"A patient with 1-2 IMDC risk factors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"858E9DD8-C1CC-2065-E053-F662850A5541","latestVersionIndicator":"Yes","beginDate":"2019-04-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-04-02","modifiedBy":"ONEDATA","dateModified":"2019-04-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"860917BC-6430-56C4-E053-F662850A4CDF","beginDate":"2019-04-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-04-08","modifiedBy":"ONEDATA","dateModified":"2019-04-08","deletedIndicator":"No"},{"value":"Poor risk","valueDescription":"International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Criteria - Poor-Risk Group","ValueMeaning":{"publicId":"6684040","version":"1","preferredName":"International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Criteria - Poor-Risk Group","longName":"6684040","preferredDefinition":"A patient with 3-6 IMDC risk factors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Criteria - Poor-Risk Group","conceptCode":"C155846","definition":"A patient with 3-6 IMDC risk factors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"858E9DD8-C1F2-2065-E053-F662850A5541","latestVersionIndicator":"Yes","beginDate":"2019-04-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-04-02","modifiedBy":"ONEDATA","dateModified":"2019-04-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"860917BC-6444-56C4-E053-F662850A4CDF","beginDate":"2019-04-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-04-08","modifiedBy":"ONEDATA","dateModified":"2019-04-08","deletedIndicator":"No"},{"value":"Favorable risk","valueDescription":"International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Criteria - Favorable-Risk Group","ValueMeaning":{"publicId":"6831269","version":"1","preferredName":"International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Criteria - Favorable-Risk Group","longName":"6831269","preferredDefinition":"A patient with 0 IMDC risk factors.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Criteria - Favorable-Risk Group","conceptCode":"C155844","definition":"A patient with 0 IMDC risk factors.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E8669DC-947C-36F1-E053-F662850AA08A","latestVersionIndicator":"Yes","beginDate":"2019-07-25","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-25","modifiedBy":"ONEDATA","dateModified":"2019-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E8669DC-9495-36F1-E053-F662850AA08A","beginDate":"2019-07-25","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-07-25","modifiedBy":"ONEDATA","dateModified":"2019-07-25","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433877","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4D2F-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"858E9DD8-C1B4-2065-E053-F662850A5541","latestVersionIndicator":"Yes","beginDate":"2019-04-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-04-02","modifiedBy":"MORENOC","dateModified":"2019-11-07","changeDescription":"11/7/2019: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[{"name":"CCR","type":"USED_BY","context":"CCR"}],"ReferenceDocuments":[{"name":"IMDC prognostic risk criteria","type":"Preferred Question Text","description":"IMDC prognostic risk criteria","url":null,"context":"Alliance"},{"name":"Classify according to the number of risk factors present:","type":"Alternate Question Text","description":"Classify according to the number of risk factors present:","url":null,"context":"CCR"}],"origin":"Alliance Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"858E9DD8-C217-2065-E053-F662850A5541","latestVersionIndicator":"Yes","beginDate":"2019-04-02","endDate":null,"createdBy":"MORENOC","dateCreated":"2019-04-02","modifiedBy":"COOPERM","dateModified":"2020-07-27","changeDescription":"11/7/2019: CM Released as part of draft content review","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}